Peter Wilden

Peter Wilden

Chairman bij POLYPEPTIDE GROUP AG

Vermogen: 282 647 $ op 31-03-2024

67 jaar
Health Technology
Finance
Consumer Non-Durables

Profiel

Peter Wilden is currently the Vice Chairman-Supervisory Board at Schlumberger GmbH since 2014.
He is also the Executive Chairman at Ferring International Center SA since 2002.
Additionally, he holds the position of Chairman at PolyPeptide Laboratories Holding (PPL) AB.
Furthermore, he is the Chairman at PolyPeptide Group AG starting from 2021.
Dr. Wilden is the Director at Project HOPE-The-People-To-People Health Foundation, Inc. since 2012 and the Director at Ferring Laboratories Ltd.
since 2004.
He is also the Managing Director at Nesos Vermögensverwaltung GmbH and a Member-Supervisory Board at Ferring GmbH.
In the past, Dr. Wilden worked as a Director at Lonza Group AG from 2004 to 2014.
He was also a Director at Aureum Realwert AG from 1999 to 2002 and Director-Group Finance at Ferring BV from 1995 to 2000.
He served as a Director at Trizell Holding SA from 2014 to 2021 and as the Chief Financial Officer & Executive Vice President at Ferring Pharmaceuticals A from 1991 to 2017.
Additionally, he worked as a Management Assistant at Krupp Mak Maschinenbau GmbH from 1986 to 1988 and as a Scientific Assistant-Information Technology Group at Kiel Institute for the World Economy in 1986.
Dr. Wilden was also the VP-Finance, Accounting & Technical Operations at FERRING Arzneimittel GmbH (Germany) from 1991 to 1996.
Dr. Wilden holds a doctorate degree from the University of Kiel, which he obtained in 1991.
He also has an MBA from the University of Kiel, which he received in 1986.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-12-2022 8 402 ( 0.03% ) 282 647 $ 31-03-2024

Actieve functies van Peter Wilden

BedrijvenFunctieBegin
SCHLUMBERGER AG Director/Board Member 11-09-2014
POLYPEPTIDE GROUP AG Chairman 01-04-2021
Director/Board Member -
Chief Executive Officer -
Chairman 01-01-2002
Chairman -
Director/Board Member 01-07-2004
Director/Board Member 01-01-2012
Alle actieve functies van Peter Wilden

Eerdere bekende functies van Peter Wilden

BedrijvenFunctieEinde
Trizell Holding SA Director/Board Member 01-06-2021
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Peter Wilden in detail bekijken

Opleiding van Peter Wilden

University of Kiel Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Peter Wilden in detail bekijken

Connecties

100 +

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
LONZA GROUP AG

Health Technology

POLYPEPTIDE GROUP AG

Health Technology

Bedrijven in privébezit14

Consumer Non-Durables

Finance

Health Technology

Health Services

Health Technology

Health Technology

Krupp Mak Maschinenbau GmbH

Finance

Finance

Health Technology

Health Technology

Finance

Trizell Holding SA

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Peter Wilden